We describe an evaluation of the international use of the Pelvic Organ Prolapse Symptom Score (POP-SS). An online survey was sent to 149 individuals who had previously requested the POP-SS and 35% responded. Ninety percent confirmed that they used the POP-SS, of which 93% were physiotherapists and 51% were located in the UK, with the remainder split between Australia, Ireland, USA and the continents of Africa, North and South America and Asia. Eighty-nine percent used the POP-SS to monitor patients’ prolapse symptoms, 78% to share information with patients, 60% to share information with clinicians and 40% to help make treatment decisions. Seventy-one percent included the POP-SS in patient records, 44% in audit and evaluation processes, and 18% in local clinical guidelines for the management of prolapse. With respect to the benefits of using the POP-SS in routine clinical care, 73% reported that clinical practice had improved, whilst 42% reported that it improved patient outcomes. Finally, 57% of users confirmed that they used the POP-SS in their research. The findings suggest that the POP-SS has global reach and is commonly used in high income countries to monitor patient symptoms of prolapse and to share information with patients, but is also reaching a number of lower and middle income countries as prolapse services begin to expand. Increased use of this brief validated symptom score would be beneficial.
|Journal||Pelvic, Obstetric and Gynaecological Physiotherapy|
|Publication status||Accepted/In press - 13 Oct 2020|
- pelvic organ prolapse, symptoms, outcome measure, online survey, impact